What exactly are we discussing?
What is the molecule, formulation and proposed use? Is it a medicine, an experimental intervention or a different type of product?
What is its regulatory status?
Is this exact product approved for the proposed use? If not, what does that mean in this situation?
What evidence applies?
Which human studies support the discussion, what did they measure, and how well do they apply to the clinical question?
What is still uncertain?
What limitations, potential harms, interactions or missing evidence should be considered?
What alternatives should be considered?
What established alternatives or further evaluation are appropriate, and why?
What professional follow-up is appropriate?
Who would be responsible for clinical decisions, follow-up and questions? Do not use this worksheet to create a monitoring or dosing plan yourself.
Are there financial interests?
Are there referral payments, sales interests or other conflicts relevant to this recommendation?
Where can I read more?
Can you point me to the official product information, relevant original studies and reliable explanations?
Supporting reading
FDA advises discussing medicine questions with a doctor. These prompts are educational and do not replace individual assessment by a qualified healthcare professional.
FDA: Concerns with unapproved GLP-1 drugs used for weight loss.